Authors


Stephanie Chang, MD

Latest:

Postoperative pain management

Exploring the available interventions for acute pain management during the preoperative, intraoperative, and postoperative phases of care.


Olutoyosi Ogunkua, MD

Latest:

Enhanced Recovery After Cesarean Section

Cesarean delivery is the most commonly performed surgery in the United States, with over 1 million infants delivered this way each year. Maternal morbidity and mortality rates in this country are higher in women undergoing cesarean delivery. To improve these outcomes, experts make a case for the application of several ERAS principles to obstetric-specific issues.


Mark Heinemeyer

Latest:

Mind-body resilience for women: A focus on depression

Here’s why we should be paying special attention to women’s depression treatment.




Patrick Campbell

Latest:

Leveraging mammograms to improve cardiovascular risk assessment

A recent study found breast arterial calcification on mammograms could help predict higher risk of stroke, cardiovascular death, and heart disease in women.


Karla F. Loken, DO, OBGYN, FACOOG

Latest:

Practical guidance for navigating complex world of insurance coverage, payer issues

Over the last year and a half, physicians around the world have been focused on managing patients, their teams, and themselves through the COVID pandemic. This has not been an easy time for physicians.


Brielle Benyon

Latest:

Cancer centers should adopt the reality that cancer has no gender, expert says

Dr. Don S. Dizon discusses how cancer centers can be more inclusive to the LGBTQ+ community, from the naming of the institutions to the types of magazines found in the waiting rooms.


Rebecca B. Perkins, MD, MSC

Latest:

2019 ASCCP guidelines: Pearls for practitioners

Consensus group discussion resulted in a shift from results-based to risk-based management for cervical cancer screening.


Lauren Biscaldi

Latest:

Breaking: FDA approves, authorizes updated monovalent COVID-19 vaccines

Bivalent COVID-19 vaccines by both Moderna and Pfizer-BioNTech are no longer authorized for use in the United States.


Marissa Fox

Latest:

HPV vaccine rates rise in teens when they can consent, research shows

State legislation that allows adolescents to choose to receive the HPV vaccine without parental interference would elevate immunization rates, according to a new study.


Claudia L. Werner, MD

Latest:

Current choices in cervical cancer screening

It is essential to expand access to all available, effective cervical cancer screening options for the most vulnerable populations. The targeted use of any particular screening modality in higher-risk populations is not supported by evidence-based guidelines; any effective screening is the priority.


Richard M. Burwick, MD, MPH

Latest:

Iron-deficiency anemia in pregnancy and the role of intravenous iron

Anemia in pregnancy should be treated due to its connection to adverse maternal and neonatal outcomes.


Nichole Tucker

Latest:

Web-based tool for family cancer history information collection

In an interview with Targeted Oncology, Melissa K. Frey, MD, discussed findings from implementing web-based health information collection of family history in patients with gynecologic cancers.


Kelly N. Wright, MD

Latest:

Surgical treatments for endometriosis

Laparoscopy remains the gold standard for diagnosis and treatment of the disease.


Staff

Latest:

IVIG safe, effective for treating pregnant patients with severe COVID-19

Intravenous immunoglobulin shows promise as a treatment option for pregnant patients with SARS-CoV-2, influenza, and other respiratory viruses.


Kristl Tomlin, MD, FACOG

Latest:

A noninfectious “infection” after cesarean delivery

Experts evaluate 3 clinical scenarios and determine the appropriate course of action.


Danielle M. Alm, PharmD, BCPS, BCPPS

Latest:

Finding the best fit

Best practices on discussing birth control for adolescents.


Austin Cox, MD

Latest:

A noninfectious “infection” after cesarean delivery

Experts evaluate 3 clinical scenarios and determine the appropriate course of action.



William Hynes, DPhil

Latest:

Violence against women and acquired brain injuries

Violence against women and resulting traumatic brain injuries increased during the COVID-19 pandemic.


Howard Curlin, MD

Latest:

Endometrial ablation in the office setting

Breaking down barriers through patient selection, new devices, and the latest techniques.


Freya Shepherd, MSc, BSc

Latest:

An update on the presentation, nosology, and causes of postpartum psychosis

Postpartum psychosis is experienced by 1 to 2 women every 1000 deliveries.


Malavika Prabhu, MD

Latest:

SMFM Consult Series #57: Evaluation and management of soft ultrasound markers for aneuploidy

In this consult series, experts from SMFM discuss the evaluation and management of soft ultrasound markers for aneuploidy.


Kartik K. Venkatesh, MD, PHD

Latest:

Diagnosis and Management of Gestational Diabetes

What every OB/GYN needs to know to manage this complication.


Jeffrey Bendix

Latest:

COVID-19's impact on patient portal utilization and disparities

A recent study analyzing patient portal use amidst the COVID-19 pandemic unveils changes in sociodemographic trends and disparities, highlighting shifts in user behavior and access challenges.


Kristi Rosa

Latest:

FDA approves dostarlimab for dMMR endometrial cancer

The FDA has granted a regular approval to dostarlimab-gxly (Jemperli; GSK) for adult patients with mismatch repair–deficient, recurrent or advanced endometrial cancer that has progressed on or after a prior platinum-containing regimen in any setting and who are not candidates for curative surgery or radiation.


Joseph Biggio, MD, MS

Latest:

SMFM Consult Series #57: Evaluation and management of soft ultrasound markers for aneuploidy

In this consult series, experts from SMFM discuss the evaluation and management of soft ultrasound markers for aneuploidy.


Courtney Marabella

Latest:

Niraparib Demonstrates PFS Benefit in Chinese Population With Advanced Ovarian Cancer

First-line maintenance treatment with the PARP inhibitor niraparib yielded a clinically meaningful and statistically significant improvement in progression-free survival vs placebo in Chinese patients with platinum-responsive advanced ovarian cancer, regardless of biomarker status, according to data from the phase 3 PRIME trial.


Tiffany Avery, MD

Latest:

Treatment validation platforms can reduce care variations and promote health equity

Emerging technology helps ensure best practices while reducing costs of care.

© 2024 MJH Life Sciences

All rights reserved.